
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2022年股票期权激励计划(草案) | 2022-04-06 | Chinese | |
| 2022年第一次临时股东大会通知 | 2022-04-06 | Chinese | |
| 2022年股票期权激励计划实施考核管理办法 | 2022-04-06 | Chinese | |
| 2022年股票期权激励计划首次授予激励对象名单 | 2022-04-06 | Chinese | |
| 2022年股票期权激励计划(草案)摘要公告 | 2022-04-06 | Chinese | |
| 第三届董事会第四十一次会议决议公告 | 2022-04-06 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 38178666 | 2022年股票期权激励计划(草案) | 2022-04-06 | Chinese | ||
| 38178659 | 2022年第一次临时股东大会通知 | 2022-04-06 | Chinese | ||
| 38178620 | 2022年股票期权激励计划实施考核管理办法 | 2022-04-06 | Chinese | ||
| 38178608 | 2022年股票期权激励计划首次授予激励对象名单 | 2022-04-06 | Chinese | ||
| 38178597 | 2022年股票期权激励计划(草案)摘要公告 | 2022-04-06 | Chinese | ||
| 38178573 | 第三届董事会第四十一次会议决议公告 | 2022-04-06 | Chinese | ||
| 38178552 | 上海荣正投资咨询股份有限公司关于天域生态环境股份有限公司2022年股票期权激励计划(草案)之独立财务顾问报告 | 2022-04-06 | Chinese | ||
| 38178535 | 关于独立董事公开征集委托投票权的公告 | 2022-04-06 | Chinese | ||
| 38178516 | 中德证券有限责任公司关于天域生态环境股份有限公司向控股子公司增资暨关联交易的核查意见 | 2022-04-06 | Chinese | ||
| 38178494 | 独立董事关于第三届董事会第四十一次会议相关事项的事前认可意见 | 2022-04-06 | Chinese | ||
| 38178482 | 天域生态关于公司对外投资进展的公告 | 2022-03-28 | Chinese | ||
| 38178463 | 天域生态关于继续对上海证券交易所问询函剩余问题回复的公告 | 2022-03-28 | Chinese | ||
| 38178436 | 独立董事关于第三届董事会第四十次会议相关议案之独立意见 | 2022-03-28 | Chinese | ||
| 38178413 | 天域生态关于收到上海证券交易所问询函延期回复的公告 | 2022-03-24 | Chinese | ||
| 38178396 | 天域生态关于提前归还部分暂时用于补充流动资金的闲置募集资金的公告 | 2022-03-14 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.